Indivior Pharmaceuticals, Inc.
INDV
$33.34
$0.742.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2,900.00% | 241.76% | 143.55% | 93.75% | 105.43% |
| Total Depreciation and Amortization | -20.00% | 75.00% | 118.18% | 127.27% | 108.33% |
| Total Amortization of Deferred Charges | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -100.00% | -61.80% | -37.61% | -69.72% | -56.48% |
| Change in Net Operating Assets | -458.70% | 86.03% | 121.74% | 124.35% | 84.35% |
| Cash from Operations | -175.00% | 183.10% | 212.37% | 149.17% | 112.00% |
| Capital Expenditure | -127.59% | -241.18% | -275.00% | -255.56% | -262.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -73.91% | 29.41% | 0.00% | 133.33% |
| Cash from Investing | -195.65% | -148.57% | -38.24% | -31.58% | 172.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 92.92% | -6,350.00% | -12,450.00% | -- | -1,900.00% |
| Issuance of Common Stock | -33.33% | -33.33% | -50.00% | -50.00% | -25.00% |
| Repurchase of Common Stock | 91.79% | 64.89% | 13.24% | -51.49% | -248.21% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 150.00% | -- | -100.00% | 0.00% | -- |
| Cash from Financing | 70.59% | 108.29% | 74.81% | 35.71% | -59.38% |
| Foreign Exchange rate Adjustments | -- | -100.00% | 0.00% | -100.00% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4,233.33% | 148.92% | 171.72% | 136.47% | 100.66% |